↓ Skip to main content

Spinal ependymoma in adults: from molecular advances to new treatment perspectives

Overview of attention for article published in Frontiers in oncology, November 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Spinal ependymoma in adults: from molecular advances to new treatment perspectives
Published in
Frontiers in oncology, November 2023
DOI 10.3389/fonc.2023.1301179
Pubmed ID
Authors

Giulia Cerretti, Federico Pessina, Enrico Franceschi, Valeria Barresi, Alessandro Salvalaggio, Marta Padovan, Renzo Manara, Vincenzo Di Nunno, Beatrice Claudia Bono, Giovanni Librizzi, Mario Caccese, Marta Scorsetti, Marta Maccari, Giuseppe Minniti, Pierina Navarria, Giuseppe Lombardi

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 19%
Unspecified 3 14%
Researcher 2 10%
Student > Doctoral Student 1 5%
Student > Ph. D. Student 1 5%
Other 2 10%
Unknown 8 38%
Readers by discipline Count As %
Medicine and Dentistry 7 33%
Neuroscience 3 14%
Unspecified 3 14%
Unknown 8 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2023.
All research outputs
#8,586,912
of 26,180,352 outputs
Outputs from Frontiers in oncology
#3,232
of 22,924 outputs
Outputs of similar age
#125,550
of 384,059 outputs
Outputs of similar age from Frontiers in oncology
#70
of 795 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 22,924 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 384,059 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 795 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.